Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
glaxosmithkline
2
×
life sciences
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
2025
acute migrane
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
bain capital
base editing
bausch health
bio
biogen
biome
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
briefing docs
car-t
celgene
cervical cancer
clinical study
clinical trial
clinical trials
commissioner
crispr
What
ipo
2
×
activity
allogene
bio
biotech
cancer
companies
crispr
days
diversity
dog
drug
firm
hasn’t
hot
immunotherapy
investors
ipos
juno
leading
line
migraine
million
nearly
new
pfizer
place
prep
remains
roundup
satsuma
securing
shares
slowed
snapped
spinout
springworks
stopped
summer
therapeutics
Language
unset
Current search:
glaxosmithkline
×
ipo
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
